Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA08020186 N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5;O C18H27NO2 289.204179
LMFA08020187 N-(3-carboxypropanoyl)-N-hydroxycadaverine 4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoic acid C9H18N2O4 218.126658
LMFA08020188 N-(3-carboxypropanoyl)-N-hydroxyputrescine 4-[(4-aminobutyl)(hydroxy)amino]-4-oxobutanoic acid C8H16N2O4 204.111008
LMFA08020189 N,2,3-Trimethyl-2-(1-methylethyl)butanamide N,2,3-trimethyl-2-(propan-2-yl)butanamide NA 10:0 C10H21NO 171.162314
LMFA08020190 N,N-diethyl-3-hydroxybut-2-enamide N,N-diethyl-3-hydroxybut-2-enamide NA 8:1;O C8H15NO2 157.110279
LMFA08020190 N,N-diethyl-3-hydroxybut-2-enamide N,N-diethyl-3-hydroxybut-2-enamide NA 8:1;O C8H15NO2 157.110279
LMFA08020191 N-Cyclopropyl-trans-2-cis-6-nonadienamide (2E,6Z)-N-cyclopropylnona-2,6-dienamide NA 12:3 C12H19NO 193.146664
LMFA08020191 N-Cyclopropyl-trans-2-cis-6-nonadienamide (2E,6Z)-N-cyclopropylnona-2,6-dienamide NA 12:3 C12H19NO 193.146664
LMFA08020192 Neopellitorine A (2E,4E)-N-(2-methylpropyl)undeca-2,4-dien-7,9-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020192 Neopellitorine A (2E,4E)-N-(2-methylpropyl)undeca-2,4-dien-7,9-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020193 N-Ethyl trans-2-cis-6-nonadienamide (2E,6Z)-N-ethylnona-2,6-dienamide NA 11:2 C11H19NO 181.146664
LMFA08020194 N-formylmaleamic acid (2Z)-4-formamido-4-oxobut-2-enoic acid NA 5:3;O3 C5H5NO4 143.021859
LMFA08020195 N-Isobutyl-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020195 N-Isobutyl-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020196 N-methyl-2-oxoglutaramic acid 5-(methylamino)-2,5-dioxopentanoic acid NA 6:2;O3 C6H9NO4 159.053159
LMFA08020197 Palmitoyl Serinol N-(1,3-dihydroxypropan-2-yl)hexadecanamide NA 19:0;O2 C19H39NO3 329.292994
LMFA08020198 Pantothenol (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide NA 9:0;O3 C9H19NO4 205.131409
LMFA08020198 Pantothenol (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide NA 9:0;O3 C9H19NO4 205.131409
LMFA08020199 phenyl [1-(N-succinylamino)pentyl]phosphonate 4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid C15H22NO6P 343.118475
LMFA08020199 phenyl [1-(N-succinylamino)pentyl]phosphonate 4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid C15H22NO6P 343.118475
LMFA08020200 Pipericine (2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide NA 22:2 C22H41NO 335.318814
LMFA08020200 Pipericine (2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide NA 22:2 C22H41NO 335.318814
LMFA08020202 S-Acetyldihydrolipoamide-E 8-(acetylsulfanyl)-6-sulfanyloctanamide C10H19NO2S2 249.085720
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08010014 (R)-dihydrolipoamide (6R)-6,8-disulfanyloctanamide C8H17NOS2 207.075155
LMFA08010015 12-amino-dodecanoicacid 12-aminolauramide C12H26N2O 214.204513
LMFA08010016 acetoacetamide 3-oxobutanamide C4H7NO2 101.047679
LMFA08010016 acetoacetamide 3-oxobutanamide C4H7NO2 101.047679
LMFA08010019 Dihydrolipoamide 6,8-disulfanyloctanimidic acid C8H17NOS2 207.075155
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010023 S-Acetyldihydrolipoamide 6-(acetylsulfanyl)-8-sulfanyloctanamide C10H19NO2S2 249.085720
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008